J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoneda, H.
Right arrow Articles by Shirai, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoneda, H.
Right arrow Articles by Shirai, M.
Agricola
Right arrow Articles by Yoneda, H.
Right arrow Articles by Shirai, M.
J Med Microbiol 52 (2003), 409-415; DOI: 10.1099/jmm.0.04992-0
© 2003 Society for General Microbiology
ISSN 0022-2615

Aspirin inhibits Chlamydia pneumoniae-induced NF-{kappa}B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth

Hiroshi Yoneda1,2, Koshiro Miura1,4, Hiroshi Matsushima1,3, Kazuro Sugi4, Tomoyuki Murakami4, Kazunobu Ouchi5,{dagger}, Katsuhiro Yamashita2,{ddagger}, Haruhide Itoh2,§, Teruko Nakazawa1, Michiyasu Suzuki2 and Mutsunori Shirai1

1–3Departments of Microbiology1, Neurosurgery2 and Pediatrics3, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan 4Department of Clinical Research, National Sanyo Hospital, Ube, Yamaguchi, 755-0241, Japan 5Saiseikai General Hospital, Shimonoseki, Yamaguchi, 751-0823, Japan

Correspondence Mutsunori Shirai mshirai{at}po.cc.yamaguchi-u.ac.jp

Received June 11, 2002
Accepted December 11, 2002

Infection with Chlamydia pneumoniae has been implicated as a potential risk factor for atherosclerosis. This study was designed to investigate the mechanisms of the anti-chlamydial activity of aspirin. A reporter gene assay for NF-{kappa}B activity, immunoblot analysis for cyclo-oxygenase (COX)-2 and radioimmunoassay for prostaglandin E2 (PGE2) were performed. Following infection of HEp-2 cells with C. pneumoniae, NF-{kappa}B was activated, COX-2 was induced and PGE2 was elevated. Aspirin inhibited NF-{kappa}B activation at a concentration of 0.1 mM, partially inhibited COX-2 induction and blocked PGE2 synthesis completely. In addition, high doses of aspirin (1 and 2 mM) inhibited chlamydial growth in HEp-2 cells, decreasing the number and size of inclusion bodies; this effect could be overcome by adding tryptophan to the culture. Indomethacin also blocked the synthesis of PGE2, but had no effect on COX-2 expression or chlamydial growth. These results indicate that aspirin not only has an anti-inflammatory activity through prevention of NF-{kappa}B activation but also has anti-chlamydial activity at high doses, possibly through depletion of tryptophan in HEp-2 cells.


{dagger}Present address: Department of Pediatrics II, Kawasaki Medical School, Kurashiki, Okayama, 701-0192, Japan.

{ddagger}Present address: Yamaguchi Rosai Hospital, Onoda, Yamaguchi, 756-0803, Japan.

§Present address: Neurosurgery, Shimonoseki National Hospital, Shimonoseki, Yamaguchi, 751-0823, Japan.

Abbreviations: COX, cyclo-oxygenase; PGE2, prostaglandin E2.




This article has been cited by other articles:


Home page
DNA ResHome page
K. Miura, H. Toh, H. Hirakawa, M. Sugii, M. Murata, K. Nakai, K. Tashiro, S. Kuhara, Y. Azuma, and M. Shirai
Genome-wide Analysis of Chlamydophila pneumoniae Gene Expression at the Late Stage of Infection
DNA Res, April 1, 2008; 15(2): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Rydkina, A. Sahni, R. B. Baggs, D. J. Silverman, and S. K. Sahni
Infection of Human Endothelial Cells with Spotted Fever Group Rickettsiae Stimulates Cyclooxygenase 2 Expression and Release of Vasoactive Prostaglandins
Infect. Immun., September 1, 2006; 74(9): 5067 - 5074.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. R. Clifton, E. Rydkina, R. S. Freeman, and S. K. Sahni
NF-{kappa}B Activation during Rickettsia rickettsii Infection of Endothelial Cells Involves the Activation of Catalytic I{kappa}B Kinases IKK{alpha} and IKK{beta} and Phosphorylation-Proteolysis of the Inhibitor Protein I{kappa}B{alpha}
Infect. Immun., January 1, 2005; 73(1): 155 - 165.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Caronzolo, V. Lucini, M. Pannacci, S. Grosso, F. Colleoni, F. Fraschini, and F. Scaglione
Glucocorticoids Increase In Vitro and In Vivo Activities of Antibiotics against Chlamydophila pneumoniae
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4878 - 4881.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Khwaja, J. Allen, J. Lynch, P. Andrews, and D. Djakiew
Ibuprofen Inhibits Survival of Bladder Cancer Cells by Induced Expression of the p75NTR Tumor Suppressor Protein
Cancer Res., September 1, 2004; 64(17): 6207 - 6213.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Rodel, D. Prochnau, K. Prager, J. Baumert, K.-H. Schmidt, and E. Straube
Chlamydia pneumoniae Decreases Smooth Muscle Cell Proliferation through Induction of Prostaglandin E2 Synthesis
Infect. Immun., August 1, 2004; 72(8): 4900 - 4904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2003 Society for General Microbiology.